en

PRODUCT DETAIL

Zubsolv 1,4 mg/0,36 mg sublingválne tablety

Code 0196D
MA number EU/1/17/1233/010
Product Form: tbl slg 28x1,4 mg/0,36 mg (blis.PVC/OPA/Al/PVC//Al/PET/papier)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Accord Healthcare S.L.U, Spain
Therapeutic Class: 19 - ANTIDOTA, DETOXICANTIA
ATC:
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07B DRUGS USED IN ADDICTIVE DISORDERS
N07BC Drugs used in opioid dependence
N07BC51 Buprenorphine, combinations
Shelf life: 48
Container: blister OPA/Al/PVC/paper/PE/Al
Route of admin.: Sublingual use
Prescription Status: Medicinal product subject to special medical prescription with skew blue stripe.
Legal basis: Article 10(3) hybrid application
MA issued: 17.12.2018
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 15.08.2022
eu-flag.png sk-flag.png